Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2091

1.

Importance of short-term continuing care plan adherence on long-term outcomes among patients discharged from residential substance use treatment.

Proctor SL, Wainwright JL, Herschman PL.

Am J Drug Alcohol Abuse. 2017 May 30:1-8. doi: 10.1080/00952990.2017.1329315. [Epub ahead of print]

PMID:
28557531
2.

Correction to Chun et al. (2017).

[No authors listed]

J Abnorm Psychol. 2017 May 29. doi: 10.1037/abn0000289. [Epub ahead of print]

PMID:
28557506
3.

Cardiorespiratory fitness and body composition of stimulant users: A baseline analysis of the STRIDE cohort.

Stoutenberg M, Rethorst CD, Vidot DC, Greer TL, Trivedi MH.

J Subst Abuse Treat. 2017 Jul;78:74-79. doi: 10.1016/j.jsat.2017.05.005. Epub 2017 May 10.

PMID:
28554607
4.

Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention.

Ali B, Green KM, Daughters SB, Lejuez CW.

Addict Behav. 2017 Oct;73:99-104. doi: 10.1016/j.addbeh.2017.04.016. Epub 2017 Apr 27.

PMID:
28500908
5.

Trait Mindfulness and Progression to Injection Use in Youth With Opioid Addiction.

Wilson JD, Vo H, Matson P, Adger H, Barnett G, Fishman M.

Subst Use Misuse. 2017 May 4:1-8. doi: 10.1080/10826084.2017.1289225. [Epub ahead of print]

PMID:
28471275
6.

Planning and Designing the Improving Addiction Care Team (IMPACT) for Hospitalized Adults with Substance Use Disorder.

Englander H, Weimer M, Solotaroff R, Nicolaidis C, Chan B, Velez C, Noice A, Hartnett T, Blackburn E, Barnes P, Korthuis PT.

J Hosp Med. 2017 May;12(5):339-342. doi: 10.12788/jhm.2736.

PMID:
28459904
7.

A Randomized Controlled Trial of a Mindfulness and Acceptance Group Therapy for Residential Substance Use Patients.

Shorey RC, Elmquist J, Gawrysiak MJ, Strauss C, Haynes E, Anderson S, Stuart GL.

Subst Use Misuse. 2017 Apr 21:1-11. doi: 10.1080/10826084.2017.1284232. [Epub ahead of print]

PMID:
28430015
8.

Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study.

McKetin R, Kothe A, Baker AL, Lee NK, Ross J, Lubman DI.

Drug Alcohol Rev. 2017 Apr 18. doi: 10.1111/dar.12528. [Epub ahead of print]

PMID:
28421682
9.

Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?

Reif S, Acevedo A, Garnick DW, Fullerton CA.

Psychiatr Serv. 2017 Apr 17:appips201600339. doi: 10.1176/appi.ps.201600339. [Epub ahead of print]

PMID:
28412900
10.

Insurance Receipt and Readiness for Opportunities under the Affordable Care Act: A National Survey of Treatment Providers for Substance Use Disorders.

Aletraris L, Edmond MB, Roman PM.

J Psychoactive Drugs. 2017 Apr-Jun;49(2):141-150. doi: 10.1080/02791072.2017.1306661. Epub 2017 Apr 13.

PMID:
28406363
11.

Depression, anxiety, and compulsive sexual behaviour among men in residential treatment for substance use disorders: The role of experiential avoidance.

Brem MJ, Shorey RC, Anderson S, Stuart GL.

Clin Psychol Psychother. 2017 Apr 11. doi: 10.1002/cpp.2085. [Epub ahead of print]

PMID:
28401660
12.

Combining medically assisted treatment and Twelve-Step programming: a perspective and review.

Galanter M.

Am J Drug Alcohol Abuse. 2017 Apr 7:1-9. doi: 10.1080/00952990.2017.1306747. [Epub ahead of print]

PMID:
28387530
13.

VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.

Ellerbe LS, Manfredi L, Gupta S, Phelps TE, Bowe TR, Rubinsky AD, Burden JL, Harris AH.

Addict Sci Clin Pract. 2017 Apr 4;12(1):10. doi: 10.1186/s13722-017-0075-z.

14.

Experiential avoidance, distress tolerance, and substance use cravings among adults in residential treatment for substance use disorders.

Shorey RC, Gawrysiak MJ, Elmquist J, Brem M, Anderson S, Stuart GL.

J Addict Dis. 2017 Mar 6:1-7. doi: 10.1080/10550887.2017.1302661. [Epub ahead of print]

PMID:
28358236
15.

Parenting self-efficacy and empowerment among expectant mothers with substance use disorders.

Zand DH, Chou JL, Pierce KJ, Pennington LB, Dickens RR, Michael J, McNamara D, White T.

Midwifery. 2017 May;48:32-38. doi: 10.1016/j.midw.2017.03.003. Epub 2017 Mar 7.

PMID:
28324807
16.

Mental health service availability and delivery at the global level: an analysis by countries' income level from WHO's Mental Health Atlas 2014.

Lora A, Hanna F, Chisholm D.

Epidemiol Psychiatr Sci. 2017 Mar 13:1-12. doi: 10.1017/S2045796017000075. [Epub ahead of print]

PMID:
28287062
17.
18.

One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder.

Hagen E, Erga AH, Hagen KP, Nesvåg SM, McKay JR, Lundervold AJ, Walderhaug E.

J Subst Abuse Treat. 2017 May;76:81-87. doi: 10.1016/j.jsat.2017.01.016. Epub 2017 Jan 31.

19.

Pre-treatment predictors of dropout from prolonged exposure therapy in patients with chronic posttraumatic stress disorder and comorbid substance use disorders.

Belleau EL, Chin EG, Wanklyn SG, Zambrano-Vazquez L, Schumacher JA, Coffey SF.

Behav Res Ther. 2017 Apr;91:43-50. doi: 10.1016/j.brat.2017.01.011. Epub 2017 Jan 25.

PMID:
28147254
20.

Long-Term Outcomes After Residential Substance Use Treatment: Relapse, Morbidity, and Mortality.

Decker KP, Peglow SL, Samples CR, Cunningham TD.

Mil Med. 2017 Jan;182(1):e1589-e1595. doi: 10.7205/MILMED-D-15-00560.

PMID:
28051978

Supplemental Content

Loading ...
Support Center